Therapeutic targeting of the conserved region within the low-complexity domain of TDP-43 is neuroprotective and extends survival in amyotrophic lateral sclerosis mice.
Overview
- Department of Pharmacology and Toxicology, College of Pharmacy, University of Arizona,Tucson, AZ USA
- Department of Psychiatry and Behavioral Sciences, Division of Neurobiology, Johns Hopkins University School of Medicine,Baltimore, MD USA
- Department of Pharmacology, Case Western Reserve University,Cleveland, OH USA
- Department of Pharmacy Practice and Science, College of Pharmacy, University of Arizona,Tucson, AZ USA
Abstract
Autosomal dominant mutations in TARDBP, encoding TAR DNA-binding protein 43 (TDP-43), cause amyotrophic lateral sclerosis (ALS), and TDP-43 pathology is a hallmark of multiple aging-associated neurodegenerative diseases. Despite its pathological role, effective therapies remain limited by the lack of safe, potent molecules targeting TDP-43 neurotoxicity. Here we show that the conserved α-helical region spanning residues 320–340 (conserved region or CR) is a therapeutically actionable target for TDP-43 neurotoxicity. Deletion of CR markedly suppressed TDP-43-induced neuronal death. Structure-based virtual screening identified XL20, a brain-penetrant small molecule that engages CR and confers neuroprotection without affecting TDP-43 splicing activity. XL20 alleviated motor neuron loss, extended survival in TDP-43 p.Ala315Thr ALS mice and enhanced neuronal function in p.Gln331Lys induced pluripotent stem cell-derived human ALS motor neurons. Mechanistically, targeting CR suppressed TDP-43 mitochondrial localization and restored mitochondrial function, likely through liquid–liquid phase separation. Our findings highlight CR as a therapeutic target for TDP-43-associated neurodegeneration and support CR-binding small molecules as therapeutic candidates.
Reproduced under the paper's license (CC BY), from the paper cited above.
Code
The paper links to its data and to no code of its authors: see the Data section.
The paper's code and data availability statement is in the Data section.
Tracing map
A tracing map links a paper to the code its authors published: this paper has none, so it has no map.
Data
Datasets cited
- bioproject:PRJNA1220042, at NCBI BioProject; found in “Data availability”
- pride:PXD060626, at PRIDE; found in “Data availability”
Data availability
The mass spectrometry proteomics data generated in this study have been deposited in the ProteomeXchange Consortium via the PRIDE partner repository under accession code PXD060626 (http://
Reproduced under the paper's license (CC BY), from the paper cited above.
Versions
The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.
Version 2, 28 September 2026
- Publisher: n/a → Nature Portfolio
Version 1, 27 September 2026: the first record
Recorded: type, language, journal, volume, issue, pages, dates, 13 authors, 3 keywords, 11 MeSH terms, 3 funders, 69 references.
Cite
This paper
Gao, J., Shukla, D., Ding, M., Qin, S., Tang, F., Guerrero, E., Vicuna, L., Xu, J., Li, H., Miyagi, M., Li, P. P., Liang, J., & Wang, X. (2026). Therapeutic targeting of the conserved region within the low-complexity domain of TDP-43 is neuroprotective and extends survival in amyotrophic lateral sclerosis mice. Nature aging, 6(8), 1667-1683. https://
BibTeX
@article{gao2026therapeu
author = {Gao, Ju and Shukla, Devanshi and Ding, Mao and Qin, Siyue and Tang, Fan and Guerrero, Evelyn and Vicuna, Lauren and Xu, Jiawei and Li, Hongling and Miyagi, Masaru and Li, Pan P. and Liang, Jingjing and Wang, Xinglong},
title = {{Therapeutic targeting of the conserved region within the low-complexity domain of TDP-43 is neuroprotective and extends survival in amyotrophic lateral sclerosis mice}},
journal = {Nature aging},
year = {2026},
month = jul,
volume = {6},
number = {8},
pages = {1667--1683},
publisher = {Nature Portfolio},
issn = {2662-8465},
doi = {10.1038/
url = {https://
pmid = {42399370},
pmcid = {PMC13472882}
}
RIS
TY - JOUR
AU - Gao, Ju
AU - Shukla, Devanshi
AU - Ding, Mao
AU - Qin, Siyue
AU - Tang, Fan
AU - Guerrero, Evelyn
AU - Vicuna, Lauren
AU - Xu, Jiawei
AU - Li, Hongling
AU - Miyagi, Masaru
AU - Li, Pan P.
AU - Liang, Jingjing
AU - Wang, Xinglong
TI - Therapeutic targeting of the conserved region within the low-complexity domain of TDP-43 is neuroprotective and extends survival in amyotrophic lateral sclerosis mice
T2 - Nature aging
J2 - Nat Aging
PY - 2026
DA - 2026/
VL - 6
IS - 8
SP - 1667
EP - 1683
SN - 2662-8465
PB - Nature Portfolio
DO - 10.1038/
UR - https://
LA - en
ER -
CSL-JSON
{
"id": "10.1038/
"type": "article-journal",
"title": "Therapeutic targeting of the conserved region within the low-complexity domain of TDP-43 is neuroprotective and extends survival in amyotrophic lateral sclerosis mice",
"container-title": "Nature aging",
"author": [
{
"family": "Gao",
"given": "Ju"
},
{
"family": "Shukla",
"given": "Devanshi"
},
{
"family": "Ding",
"given": "Mao"
},
{
"family": "Qin",
"given": "Siyue"
},
{
"family": "Tang",
"given": "Fan"
},
{
"family": "Guerrero",
"given": "Evelyn"
},
{
"family": "Vicuna",
"given": "Lauren"
},
{
"family": "Xu",
"given": "Jiawei"
},
{
"family": "Li",
"given": "Hongling"
},
{
"family": "Miyagi",
"given": "Masaru"
},
{
"family": "Li",
"given": "Pan P."
},
{
"family": "Liang",
"given": "Jingjing"
},
{
"family": "Wang",
"given": "Xinglong"
}
],
"container-title-short":
"volume": "6",
"issue": "8",
"page": "1667-1683",
"DOI": "10.1038/
"PMID": "42399370",
"PMCID": "PMC13472882",
"ISSN": "2662-8465",
"publisher": "Nature Portfolio",
"URL": "https://
"language": "en",
"issued": {
"date-parts": [
[
2026,
7,
3
]
]
}
}
Similar papers
The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.
- [1] doi:10.1186/s13024-026-00944-2
- TDP-43: [GU]-ardian of the transcriptome.Journal: Molecular neurodegenerationIn common: other condition, 31 references
- [2] doi:10.1371/journal.pbio.3003662
- A quantitative cell-based reporter links TDP-43 aggregation and dysfunction to define pathogenic mechanisms.Journal: PLoS biologyIn common: other condition, 13 references
- [3] doi:10.1016/j.celrep.2024.115205 [code]
- Opposing roles of p38α-mediated phosphorylation and PRMT1-mediated arginine methylation in driving TDP-43 proteinopathy.Journal: Cell reportsIn common: other condition, 11 references
- [4] doi:10.1038/s41467-025-59679-1 [code]
- Single-cell RNA-sequencing reveals early mitochondrial dysfunction unique to motor neurons shared across FUS- and TARDBP-ALS.Journal: Nature communicationsIn common: other condition, 9 references
- [5] doi:10.1016/j.celrep.2024.115113
- TDP43 autoregulation gives rise to dominant negative isoforms that are tightly controlled by transcriptional and post-translational mechanisms.Journal: Cell reportsIn common: other condition, mouse, 6 references
- [6] doi:10.1038/s41467-026-68346-y
- From TDP-43/
RNA complex formation to disease-linked TDP-43 aggregation through a structural and cellular approach. Journal: Nature communicationsIn common: other condition, 6 references - [7] doi:10.1080/19768354.2026.2643998
- Enhancer RNA-mediated transcriptional regulation of TDP-43 during early neural lineage specification.Journal: Animal cells and systemsIn common: 7 references
- [8] doi:10.1186/s13024-024-00732-w [code]
- Elevated nuclear TDP-43 induces constitutive exon skipping.Journal: Molecular neurodegenerationIn common: mouse, 6 references
- [9] doi:10.1016/j.pneurobio.2022.102297 [code]
- Aberrant neural activity in prefrontal pyramidal neurons lacking TDP-43 precedes neuron loss.Journal: Progress in neurobiologyIn common: other condition, mouse, 6 references
- [10] doi:10.15252/embj.2022111719
- Loss of TDP-43 oligomerization or RNA binding elicits distinct aggregation patterns.Journal: The EMBO journalIn common: other condition, 6 references
Contribute
The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.
Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.
Claim this paper
Correct its record
Say what each link of this record is, remove the ones that are not the paper's, add the ones that are missing. The correction becomes a new version of the record, in its Versions section.
Request its removal
To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).
Discussion, reproductions, activity
Discussion: code errors and mismatches between the code and the paper about this paper and its code, from readers and its authors, beside the paper and its tracing map.
Reproductions: reports from readers who ran the authors' code and did not get the paper's result, what they ran, with which environment, commit and data.
Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.
